vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and InfuSystem Holdings, Inc (INFU). Click either name above to swap in a different company.

InfuSystem Holdings, Inc is the larger business by last-quarter revenue ($36.2M vs $18.7M, roughly 1.9× HEALTHY CHOICE WELLNESS CORP.). InfuSystem Holdings, Inc produced more free cash flow last quarter ($7.0M vs $-927.1K).

InfuSystem Holdings, Inc. is a U.S.-headquartered healthcare provider specializing in infusion therapy solutions. It supplies programmable infusion pumps, matching disposable medical consumables, and professional clinical support services, serving oncology clinics, home healthcare providers, and acute care facilities across North America.

HCWC vs INFU — Head-to-Head

Bigger by revenue
INFU
INFU
1.9× larger
INFU
$36.2M
$18.7M
HCWC
More free cash flow
INFU
INFU
$7.9M more FCF
INFU
$7.0M
$-927.1K
HCWC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCWC
HCWC
INFU
INFU
Revenue
$18.7M
$36.2M
Net Profit
$-1.7M
Gross Margin
39.1%
56.4%
Operating Margin
-7.6%
10.3%
Net Margin
-8.9%
Revenue YoY
7.0%
Net Profit YoY
EPS (diluted)
$-0.05
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
INFU
INFU
Q4 25
$18.7M
$36.2M
Q3 25
$19.0M
$36.5M
Q2 25
$20.2M
$36.0M
Q1 25
$20.3M
$34.7M
Q4 24
$33.8M
Q3 24
$18.2M
$35.3M
Q2 24
$33.7M
Q1 24
$32.0M
Net Profit
HCWC
HCWC
INFU
INFU
Q4 25
$-1.7M
Q3 25
$-1.2M
$2.3M
Q2 25
$-339.4K
$2.6M
Q1 25
$-712.4K
$-267.0K
Q4 24
Q3 24
$-2.7M
$1.8M
Q2 24
$717.0K
Q1 24
$-1.1M
Gross Margin
HCWC
HCWC
INFU
INFU
Q4 25
39.1%
56.4%
Q3 25
38.8%
57.1%
Q2 25
40.1%
55.2%
Q1 25
38.8%
55.2%
Q4 24
53.8%
Q3 24
38.4%
53.9%
Q2 24
49.5%
Q1 24
51.5%
Operating Margin
HCWC
HCWC
INFU
INFU
Q4 25
-7.6%
10.3%
Q3 25
-3.2%
10.4%
Q2 25
-0.2%
10.5%
Q1 25
-2.0%
1.8%
Q4 24
7.7%
Q3 24
-2.0%
9.2%
Q2 24
5.5%
Q1 24
-2.6%
Net Margin
HCWC
HCWC
INFU
INFU
Q4 25
-8.9%
Q3 25
-6.4%
6.2%
Q2 25
-1.7%
7.2%
Q1 25
-3.5%
-0.8%
Q4 24
Q3 24
-14.6%
5.1%
Q2 24
2.1%
Q1 24
-3.5%
EPS (diluted)
HCWC
HCWC
INFU
INFU
Q4 25
$-0.05
$0.09
Q3 25
$-0.09
$0.11
Q2 25
$-0.03
$0.12
Q1 25
$-0.07
$-0.01
Q4 24
$0.05
Q3 24
$-0.29
$0.08
Q2 24
$0.03
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
INFU
INFU
Cash + ST InvestmentsLiquidity on hand
$3.0M
$3.2M
Total DebtLower is stronger
$7.3M
$19.6M
Stockholders' EquityBook value
$7.3M
$57.3M
Total Assets
$33.5M
$100.6M
Debt / EquityLower = less leverage
1.00×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
INFU
INFU
Q4 25
$3.0M
$3.2M
Q3 25
$3.0M
$955.0K
Q2 25
$4.7M
$720.0K
Q1 25
$1.8M
$1.5M
Q4 24
$527.0K
Q3 24
$1.8M
$380.0K
Q2 24
$146.0K
Q1 24
$822.0K
Total Debt
HCWC
HCWC
INFU
INFU
Q4 25
$7.3M
$19.6M
Q3 25
$8.5M
$20.9M
Q2 25
$9.7M
$26.3M
Q1 25
$10.6M
$28.7M
Q4 24
$23.9M
Q3 24
$11.6M
$28.0M
Q2 24
$34.2M
Q1 24
$29.9M
Stockholders' Equity
HCWC
HCWC
INFU
INFU
Q4 25
$7.3M
$57.3M
Q3 25
$5.9M
$55.5M
Q2 25
$5.8M
$54.5M
Q1 25
$2.1M
$55.1M
Q4 24
$57.5M
Q3 24
$2.9M
$55.5M
Q2 24
$53.5M
Q1 24
$52.3M
Total Assets
HCWC
HCWC
INFU
INFU
Q4 25
$33.5M
$100.6M
Q3 25
$33.7M
$98.9M
Q2 25
$36.4M
$100.8M
Q1 25
$34.1M
$104.3M
Q4 24
$103.6M
Q3 24
$33.2M
$105.3M
Q2 24
$108.5M
Q1 24
$104.8M
Debt / Equity
HCWC
HCWC
INFU
INFU
Q4 25
1.00×
0.34×
Q3 25
1.43×
0.38×
Q2 25
1.69×
0.48×
Q1 25
5.01×
0.52×
Q4 24
0.41×
Q3 24
3.95×
0.50×
Q2 24
0.64×
Q1 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
INFU
INFU
Operating Cash FlowLast quarter
$-855.1K
$7.1M
Free Cash FlowOCF − Capex
$-927.1K
$7.0M
FCF MarginFCF / Revenue
-5.0%
19.3%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
INFU
INFU
Q4 25
$-855.1K
$7.1M
Q3 25
$-308.7K
$8.5M
Q2 25
$1.1M
$7.0M
Q1 25
$1.1M
$1.8M
Q4 24
$7.9M
Q3 24
$9.8M
Q2 24
$2.3M
Q1 24
$377.0K
Free Cash Flow
HCWC
HCWC
INFU
INFU
Q4 25
$-927.1K
$7.0M
Q3 25
$-351.3K
$8.4M
Q2 25
$988.6K
$6.8M
Q1 25
$965.3K
$1.6M
Q4 24
$7.4M
Q3 24
$9.8M
Q2 24
$2.0M
Q1 24
$195.0K
FCF Margin
HCWC
HCWC
INFU
INFU
Q4 25
-5.0%
19.3%
Q3 25
-1.8%
23.1%
Q2 25
4.9%
18.9%
Q1 25
4.8%
4.7%
Q4 24
21.9%
Q3 24
27.7%
Q2 24
5.9%
Q1 24
0.6%
Capex Intensity
HCWC
HCWC
INFU
INFU
Q4 25
0.4%
0.4%
Q3 25
0.2%
0.2%
Q2 25
0.4%
0.6%
Q1 25
0.6%
0.4%
Q4 24
1.6%
Q3 24
0.1%
Q2 24
1.0%
Q1 24
0.6%
Cash Conversion
HCWC
HCWC
INFU
INFU
Q4 25
Q3 25
3.76×
Q2 25
2.70×
Q1 25
Q4 24
Q3 24
5.45×
Q2 24
3.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

INFU
INFU

Patient Services$20.0M55%
Device Solutions$14.4M40%
Other$1.9M5%

Related Comparisons